title: Allelic selection of amplicons in glioblastoma revealed by combining somatic and germline analysis.
abstract: Cancer is a disease driven by a combination of inherited risk alleles coupled with the acquisition of somatic mutations, including amplification and deletion of genomic DNA. Potential relationships between the inherited and somatic aspects of the disease have only rarely been examined on a genome-wide level. Applying a novel integrative analysis of SNP and copy number measurements, we queried the tumor and normal-tissue genomes of 178 glioblastoma patients from the Cancer Genome Atlas project for preferentially amplified alleles, under the hypothesis that oncogenic germline variants will be selectively amplified in the tumor environment. Selected alleles are revealed by allelic imbalance in amplification across samples. This general approach is based on genetic principles and provides a method for identifying important tumor-related alleles. We find that SNP alleles that are most significantly overrepresented in amplicons tend to occur in genes involved with regulation of kinase and transferase activity, and many of these genes are known contributors to gliomagenesis. The analysis also implicates variants in synapse genes. By incorporating gene expression data, we demonstrate synergy between preferential allelic amplification and expression in DOCK4 and EGFR. Our results support the notion that combining germline and tumor genetic data can identify regions relevant to cancer biology.
authors.affiliation: Department of Genetics, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America.
authors.forename: Thomas
authors.initials: T
authors.lastname: LaFramboise
authors.forename: Ninad
authors.initials: N
authors.lastname: Dewal
authors.forename: Katherine
authors.initials: K
authors.lastname: Wilkins
authors.forename: Itsik
authors.initials: I
authors.lastname: Pe'er
authors.forename: Matthew L
authors.initials: ML
authors.lastname: Freedman
mesh_terms: D000483:Alleles; D066246:ErbB Receptors / Q000235:genetics; D020690:GTPase-Activating Proteins / Q000235:genetics; D005784:Gene Amplification / Q000235:genetics*; D015894:Genome, Human / Q000235:genetics; D005854:Germ Cells / Q000378:metabolism*; D005909:Glioblastoma / Q000235:genetics* / Q000473:pathology; D006801:Humans; D016017:Odds Ratio; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D012641:Selection, Genetic
chemical_list: C510122:DOCK4 protein, human; D020690:GTPase-Activating Proteins; D066246:ErbB Receptors
references.citation: Cancer Res. 2008 Jan 1;68(1):14-7
references.pmid: 18172290
references.citation: Cancer Res. 2003 Aug 15;63(16):4849-53
references.pmid: 12941805
references.citation: Am J Hum Genet. 1993 Mar;52(3):506-16
references.pmid: 8447318
references.citation: Nat Genet. 2003 Aug;34(4):403-12
references.pmid: 12881723
references.citation: Nat Genet. 2008 Oct;40(10):1240-4
references.pmid: 18758463
references.citation: Proc Natl Acad Sci U S A. 1971 Apr;68(4):820-3
references.pmid: 5279523
references.citation: Nat Genet. 2010 May;42(5):454-8
references.pmid: 20400965
references.citation: Proc Natl Acad Sci U S A. 1992 May 15;89(10):4309-13
references.pmid: 1584765
references.citation: Nat Genet. 2009 Apr;41(4):455-9
references.pmid: 19287384
references.citation: Sci Signal. 2009 Sep 08;2(87):re6
references.pmid: 19738203
references.citation: Nat Genet. 2009 Apr;41(4):446-9
references.pmid: 19287382
references.citation: Cell Oncol. 2007;29(5):399-408
references.pmid: 17726262
references.citation: Nat Genet. 2009 Aug;41(8):905-8
references.pmid: 19578366
references.citation: J Neurosci Res. 2008 Nov 1;86(14):3052-61
references.pmid: 18615735
references.citation: Proc Natl Acad Sci U S A. 1987 Oct;84(19):6899-903
references.pmid: 3477813
references.citation: Nat Rev Mol Cell Biol. 2008 Sep;9(9):690-701
references.pmid: 18719708
references.citation: Nat Genet. 2003 Mar;33(3):357-65
references.pmid: 12567188
references.citation: Cancer Cell. 2010 Jan 19;17(1):98-110
references.pmid: 20129251
references.citation: PLoS Comput Biol. 2005 Nov;1(6):e65
references.pmid: 16322765
references.citation: Bioinformatics. 2010 Feb 15;26(4):518-28
references.pmid: 20031965
references.citation: Cancer Res. 2007 Aug 1;67(15):7203-11
references.pmid: 17671188
references.citation: Clin Cancer Res. 2008 Feb 15;14(4):957-60
references.pmid: 18281526
references.citation: J Pathol. 2007 Mar;211(4):481-8
references.pmid: 17294421
references.citation: Nat Genet. 2000 May;25(1):25-9
references.pmid: 10802651
references.citation: Nat Genet. 2009 Apr;41(4):450-4
references.pmid: 19287385
references.citation: Br J Cancer. 2009 Dec 15;101(12):1995-2004
references.pmid: 19904263
references.citation: Clin Cancer Res. 2009 Oct 1;15(19):6258-66
references.pmid: 19789313
references.citation: Am J Pathol. 2007 May;170(5):1445-53
references.pmid: 17456751
references.citation: Cell. 2003 Mar 7;112(5):673-84
references.pmid: 12628187
references.citation: Neuro Oncol. 2007 Jul;9(3):291-7
references.pmid: 17504929
references.citation: Science. 1976 Oct 1;194(4260):23-8
references.pmid: 959840
references.citation: Nature. 2008 Oct 23;455(7216):1061-8
references.pmid: 18772890
references.citation: Bioinformatics. 2008 Jul 15;24(14):1650-1
references.pmid: 18511468
references.citation: Nat Genet. 2006 Aug;38(8):904-9
references.pmid: 16862161
references.citation: N Engl J Med. 2005 Nov 10;353(19):2012-24
references.pmid: 16282176
references.citation: Int J Cancer. 2006 Jan 15;118(2):505-8
references.pmid: 16049965
references.citation: Oncogene. 2007 Jun 14;26(28):4171-8
references.pmid: 17311004